Literature DB >> 16360410

Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.

Rashna Madan1, Matthew B Smolkin, Rubina Cocker, Rana Fayyad, Maja H Oktay.   

Abstract

Focal adhesion kinase (FAK) is one of the central signaling molecules found at focal adhesion sites, which are specific areas on the cell membrane where cells attach to extracellular matrix proteins. Focal adhesion kinase interacts with multiple signaling and adaptor molecules and effects several signaling pathways. Overexpression of FAK and its substrate c-Src has been implicated in malignant transformation and acquisition of an invasive tumor phenotype of different tissues. Overexpression of the multidomain protein paxillin, which is also a FAK ligand and a c-Src substrate, has been associated with less malignant tumor behavior. The purpose of this study was to analyze the involvement of integrin signaling molecules FAK, c-Src, and paxillin in malignant transformation of the breast epithelium. Using phosphospecific antibodies FAK-pY(397) and Src-pY(416), we demonstrated that neither activation of FAK nor activation of c-Src correlates with development of invasive tumor properties. However, activation of both FAK and c-Src correlates with malignant transformation. We further demonstrated that overexpression of paxillin also correlates with malignant transformation and is a marker of a less invasive tumor phenotype. Using tissue microarray, we demonstrated that expression and activation of paxillin inversely correlated with lymph node metastases and lymphovascular invasion, respectively. No correlation between paxillin expression and activation and tumor grade, estrogen, progesterone, and Her2/Neu receptor expression was found. In summary, focal adhesion proteins FAK and c-Src can be used as markers of malignant transformation in epithelial cells but not invasive phenotype, whereas expression and activation of paxillin may represent a good prognosticator in breast carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16360410     DOI: 10.1016/j.humpath.2005.09.024

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  32 in total

1.  MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells.

Authors:  Jun Qin; Feiran Wang; Haiyan Jiang; Junfei Xu; Yasu Jiang; Zhiwei Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Expression of paxillin in laryngeal squamous cell carcinoma and its prognostic value.

Authors:  Lianqing Li; Jing Wang; Lei Gao; Lili Gong
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  Digital holography of intracellular dynamics to probe tissue physiology.

Authors:  Daniel Merrill; Ran An; John Turek; David D Nolte
Journal:  Appl Opt       Date:  2015-01-01       Impact factor: 1.980

Review 4.  Focal adhesion kinase as a cancer therapy target.

Authors:  Vita M Golubovskaya
Journal:  Anticancer Agents Med Chem       Date:  2010-12       Impact factor: 2.505

5.  Paxillin controls endothelial cell migration and tumor angiogenesis by altering neuropilin 2 expression.

Authors:  Alexandra E German; Tadanori Mammoto; Elisabeth Jiang; Donald E Ingber; Akiko Mammoto
Journal:  J Cell Sci       Date:  2014-02-12       Impact factor: 5.285

6.  Diverse roles for the paxillin family of proteins in cancer.

Authors:  Nicholas O Deakin; Jeanine Pignatelli; Christopher E Turner
Journal:  Genes Cancer       Date:  2012-05

7.  Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling.

Authors:  Yuliya Pylayeva; Kelly M Gillen; William Gerald; Hilary E Beggs; Louis F Reichardt; Filippo G Giancotti
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

8.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 9.  Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis.

Authors:  Ming Luo; Jun-Lin Guan
Journal:  Cancer Lett       Date:  2009-07-29       Impact factor: 8.679

10.  Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.

Authors:  Emy Behmoaram; Krikor Bijian; Su Jie; Yingjie Xu; Andrew Darnel; Tarek A Bismar; Moulay A Alaoui-Jamali
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.